Clinical Trials Logo

Filter by:
NCT ID: NCT05561855 Completed - Clinical trials for Diabetes Mellitus, Type 2

T2DM Intensity Lifestyle Intervention

Start date: October 7, 2022
Phase: N/A
Study type: Interventional

This RCT study will evaluate the effect of a lifestyle intervention on overweight or obese patients with type 2 diabetes mellitus. The primary hypothesis is that the mHealth-based intensive lifestyle intervention is sufficient to achieve weight loss and maintain glycated hemoglobin control.

NCT ID: NCT05561699 Not yet recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

Sequential Preoperative Penpulimab Combined With Chemoradiotherapy(CRT) for Locally Advanced Esophageal Squamous Cell Cancer

SPEED
Start date: September 28, 2022
Phase: N/A
Study type: Interventional

This study used an open single center study design to observe the efficacy and safety of Penpulimab combined with Chemoradiotherapy(CRT) in preoperative T2,3,4aN0-1-2M0 esophageal squamous cell carcinoma (ESCC).

NCT ID: NCT05561686 Not yet recruiting - Clinical trials for HER2-positive Breast Cancer

Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer

Start date: October 1, 2022
Phase:
Study type: Observational

Pyrotinib is currently being investigated in both registration studies and investigator-initiated studies in the neoadjuvant and adjuvant setting for HER2-positive breast cancer, all of which are RCTs, but randomized clinical studies have selected specific populations in defined settings, which may differ from the actual clinical setting. Given the limited real-world data on pyrotinib, real-world studies focusing on neoadjuvant therapy have not been reported. At present, we hope to collect the data of neoadjuvant therapy for HER2-positive breast cancer patients who have been prescribed pyrotinib, and explore the efficacy and safety of pyrotinib-based neoadjuvant therapy for HER2-positive early or locally advanced breast cancer patients; exploratory analysis to explore the correlation between TMB levels and pCR rate of neoadjuvant therapy in HER2-positive breast cancer patients, and the effect of pyrotinib-based neoadjuvant therapy on intestinal flora.

NCT ID: NCT05561660 Recruiting - Migraine Clinical Trials

COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2)

Start date: October 1, 2022
Phase: Phase 4
Study type: Interventional

Migraine attacks are episodic disorder that affects approximately 12% of the population, and studies have shown that 41-48% of migraineurs have a combination of patent foramen ovale (PFO). Clinical Observational studies have been linking PFO occlusion with the effectiveness in improving migraine symptoms and reducing the frequency of attacks. However, several RCTs have shown negative primary results, making it unclear whether PFO occlusion is effective in treating migraine. Our study is a prospective, double-blind, multi-center, and randomized study designed to test the effectiveness of migraine alleviation by performing percutaneous closure of patent foramen ovale in patients who are also diagnosed with PFO and migraine.

NCT ID: NCT05561361 Recruiting - Clinical trials for Primary Aldosteronism

The Effect of SAAE on Vascular Endothelial Function in PA Patients

Start date: October 1, 2022
Phase:
Study type: Observational

The study aims to assess the effect of superselective adrenal arterial embolization on vascular endothelial function in patients with primary aldosteronism based on brachial artery flow-mediated relaxation

NCT ID: NCT05561348 Recruiting - Parkinson Disease Clinical Trials

The Effect and Mechanism of Transcutaneous Auricular Vagus Nerve Stimulation on Gait Impairments in PD

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

This study is a double blind comparative study examining the effectiveness of the transcutaneous auricular vagus nerve stimulation treatment on Parkinson's disease patients . We hypothesize that treatment using transcutaneous auricular vagus nerve stimulation will improve gait impairments and cortical activity in Parkinson's disease patients.

NCT ID: NCT05561309 Active, not recruiting - Clinical trials for Total Knee Arthroplasty

Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain Management

Start date: October 20, 2022
Phase: Phase 2
Study type: Interventional

Phase Ⅱ, randomized, double-blind, comparator-controlled study to evaluate the efficacy, safety and pharmacokinetics of single injection adductor canal block with HR18034 for postoperative pain management compared with ropivacaine.

NCT ID: NCT05561088 Recruiting - Clinical trials for Acute Ischemic Stroke

Efficacy and Safety of Head Acupuncture After Mechanical Thrombectomy for Acute Ischemic Stroke

HEALTH
Start date: April 27, 2023
Phase: N/A
Study type: Interventional

To evaluate the efficacy and safety of head acupuncture combined with endovascular therapy for cerebral infarction compared with endovascular therapy alone

NCT ID: NCT05561036 Recruiting - Desmoid Tumor Clinical Trials

A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor

Start date: September 29, 2020
Phase: Phase 3
Study type: Interventional

The aim of this study was to evaluate the efficacy and safety of liposomal doxorubicin in the treatment of desmoid tumors. Unless the subject withdraws from the trial voluntarily, or the researcher considers that the subject is not suitable for further trial, each subject will be treated until the disease progresses or the toxic and side effects caused by the drug are intolerable, and then enter the survival follow-up period

NCT ID: NCT05560997 Recruiting - Clinical trials for Non-Alcoholic Fatty Liver Disease

Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease

Start date: January 5, 2016
Phase:
Study type: Observational

The purpose of this study was to use machine learning to explore a more precise classification of NAFLD subgroups towards informing individualized therapy.